At Astrum, we believe data is the true currency of drug development. The speed, quality and integrity of your data define not only regulatory approval but also investor confidence.
Our data and technology solutions ensure that every dataset is traceable, regulator trusted and investor relevant, supporting studies from first in human through post marketing and non interventional research.
Driving value at every critical milestone of your clinical journey.
Data structured to strengthen fundraising, licensing and exit milestones.
Compliance with ICH-GCP, CDISC and 21 CFR Part 11 standards, validated through FDA, EMA and ANVISA inspections.
Centralised oversight and intelligent automation that accelerate timelines.
Traceable, inspection-ready datasets that reduce risk and build trust at every stage.
Integrated Phase I–IV and NIS expertise, linking early clinical data with late-phase and real-world insights.
more than 1,000 studies supported with regulator-ready datasets.
a unified data environment connecting science, operations and investors.
data that strengthens both clinical outcomes and funding narratives.
Ready to make your data work harder for you?